Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria

Health Policy and Planning

Volumn 24, Issue 3, 2009, Pages 189-196

  Uzochukwu, B S C ^a   Onwujekwe, O E ^a   Onoka, A C ^a   Okoli, C ^a   Uguru, N P ^a   Chukwuogo, O I ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

Adherence; AIDS; Anti retroviral therapy; Compliance; Determinants; HIV; Treatment

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFICACY; EDUCATIONAL STATUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALARIA; MALE; NIGERIA; SEX DIFFERENCE; SOCIAL INTERACTION; SOCIAL STATUS; TREATMENT REFUSAL; UNSPECIFIED SIDE EFFECT;

ANTI-RETROVIRAL AGENTS; CROSS-SECTIONAL STUDIES; DRUG COSTS; FEMALE; FINANCING, GOVERNMENT; HIV SEROPOSITIVITY; HUMANS; MALE; NIGERIA; PATIENT COMPLIANCE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 65349104025     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czp006     Document Type: Article

References (46)

1. Avert, undated. AIDS treatment targets and results. Online at: http:// www.avert.org/aidstarget.htm, accessed 4 July 2006.
2. Bond W, Hussar DA. 1991. Detection of methods and strategies for improving medication compliance. American Journal of Public Health 81: 1978-88.
3. Cheevers L. 2000. Adherence issues and strategies. Medscape HIV/AIDS: Annual Update 2000. New York: Medscape Inc. Online at: http:// www.medscape.com.
4. Chesney MA, Ickovics JR, Chambers DB et al. 2000. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care 12: 255-66.
5. Coetzee D, Boulle A, Hildebrand K et al. 2004a. Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS 18(Suppl. 3): S27-S31.
6. Coetzee D, Hildebrand K, Boulle A et al. 2004b. Outcomes after two years of providind antiretroviral treatment in Khayelitsha, South Africa. AIDS 18: 887-95.
7. Daniel OJ. 2004. Adherence pattern to ARV drugs among AIDS patients on self-purchased drugs and those on free medications in Sagamu, Nigeria. XV International AIDS Conference, Bangkok, abstract WePeB5768.
8. Eldred LJ, Wu AW, Chaisson RE et al. 1998. Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndrome 18: 117-25. Enugu State Government. 2003. State Health Policy, 2003. Enugu, Nigeria.
9. Farmer P, Leandra F, Mukherjee HS et al. 2001. Community-based approaches to HIV treatment in resource-poor settings. The Lancet 58: 404-9.
10. Federal Ministry of Health. 2006. Technical Report on 2005 National HIV/Syphilis Sero-prevalence Sentinel Survey. Abuja, Nigeria.
11. Friedland GH, Williams A. 1999. Attaining higher goals in HIV treatment: the central importance of adherence. AIDS 13(Suppl. 1): S61-72.
12. Golin CE, Liu H, Hays RD et al. 2002. A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine 17: 756-65.
13. Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM. 2001. Preventing antiretroviral anarchy in Africa. The Lancet 358: 410-4.
14. Ickovics JR, Meade CS. 2002. Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences. Journal of Acquired Immune Deficiency Syndrome 31(Suppl. 3): S98-102.
15. Iliyasu Z, Kabir M, Abubakar IS et al. 2005. Compliance to antiretroviral therapy among AIDS patients in Aminu Kano Teaching Hospital, Kano, Nigeria. Nigerian Journal of Medicine 14: 290-4.
16. Kebede D, Fikre H, Sibhatu B, Alemayehu A, Kebede BB. 2008. Defaulters from antiretroviral treatment in Jimma University Specialized Hospital, Southwest Ethiopia. Tropical Medicine and International Health 13: 328-33.
17. Keith A. 2004. Is paying for treatment affecting adherence in Africa? Presentation at the XV International AIDS Conference, Bangkok, 27 July 2004.
18. Lambo E. 2006. Nigeria has established 74 ARV treatment centers nationwide. HIV/AIDS News, 15 March.
19. Lange J, Perriens J, Kuritzeks D, Zewdie D. 2004. What policymakers should know about drug resistance and adherence in the context of scaling up treatment of HIV infection. AIDS 18(Suppl. 3): S69-S74.
20. Maskew M, MacPhail P, Menezes C, Rubel D. 2007. Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. South African Medical Journal 97: 853-7.
21. Max B, Sherer R. 2000. Management of the adverse effects of antiretroviral therapy and medication adherence. Clinical Infectious Diseases 30: S96-116.
22. Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. 2004. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatric Infectious Disease Journal 23: 103541.
23. Miller LG. 2000. Adherence to combination antiretroviral therapy: syn- thesis of the literature and clinical implications. AIDS 10: 177-85.
24. Mills EJ, Nachega JB, Bangsberg DR et al. 2006a. Adherence to HAART: A systematic review of developed and developing nation patient- reported barriers and facilitators. PLoS Medicine 3: e438.
25. Mills EJ, Nachega JB, Buchan I et al. 2006b. Adherence to antiretroviral therapy in Sub-Saharan Africa and North America: a meta- analysis. Journal of the American Medical Association 296: 679-90.
26. Montessori V, Heath KV, Yip B et al. 2000. Predictors of adherence with triple combination antiretroviral therapy [abstract 72]. 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, 30 January-2 February 2000.
27. Moyle G. 2005. Drugs for HIV: strategies for use. Medicine 33: 33-37.
28. Mukhtar-Yola M, Adeleke S, Gwarzo D, Ladan Z. 2006. Preliminary investigation of adherence to antiretroviral therapy among children in Aminu Kano Teaching Hospital, Nigeria. African Journal of AIDS Research 5: 141-4.
29. Nachega JB, Knowton AR, deLuca A et al. 2005. Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. Presented at: State of the Science Meeting on Research to Improve Antiretroviral Therapy Adherence; 11-12 November, New Haven, CT. Abstract 14.
30. Odutola A. 2004. ARV treatment in Africa. Centre for Health Policy and Strategic Studies, Lagos, Nigeria. Online at: http://www. academic.udayton.edu/ health/06world/africa04.htm.
31. Orell C, Bansberg DR, Badri M, Wood R. 2003. Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS 17: 1369-75.
32. Osterberg L, Blaschke T. 2005. Adherence to medication. New England Journal of Medicine 353: 487-97.
33. Poppa A, Davidson D, Deutsch J et al. 2004. British HIV Association (BHIVA)/British Association for sexual health and HIV guidelines on provision of adherence support to individuals receiving antiretroviral therapy (2003). HIV Medicine 5(Suppl. 2): 46-60.
34. Reynolds NR. 2004. Adherence to antiretroviral therapies: state of the science. Current HIV Research 2: 207-14.
35. Rosen S, Fox MP, Gill CJ. 2007. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Medicine 4: e298.
36. Sethi AK. 2004. Adherence and HIV drug resistance. The Hopkins HIV Report, January 2004. Online at: http://www.hopkinsids.edu/publications/report/ jan04-4.html/bell.
37. Severe P, Leger P, Charles M et al. 2005. Antiretroviral therapy in a thousand patients with AIDS in Haiti. New England Journal of Medicine 353: 2325-34.
38. Simpson J. 2006. Challenges for improving medication adherence. Journal of the American Medical Association 296: 2614-6.
39. Stout BD, Maria PL, Niccolai LM. 2004. Nonadherence to antiretroviral therapy in HIV-positive patients in Costa Rica. AIDS Patient Care and STDs 18: 297-304.
40. UNAIDS. 2008. 2008 Report on the global AIDS epidemic. Geneva: UNAIDS. Online at: http://www.unaids.org/en/KnowledgeCentre/HIVData/ GlobalReport/2008/
41. Van Servellen G, Chang B, Garcia L, Lombardi E. 2002. Individual and system level factors associated with treatment nonadherence in human immunodeficiency virus-infected men and women. AIDS Patient Care and STDs 16: 269-81.
42. WHO. 2006. Global access to HIV therapy tripled in past two years, but significant challenges remain. WHO press release, 28 March 2006. Geneva: World Health Organization.
43. WHO. 2007. World health statistics 2007. Geneva: World Health Organization.
44. WHO, PSM, Forum for Collaborative HIV Research. 2008. ARV drugs adverse events, case definition, toxicity grading and laboratory diagnosis. Meeting, WHO Geneva, 28-29 February 2008.
45. Williams PL, Storm D, Montepiedra G et al. 2006. Predictors of adherence to antiretroviral medications in children and adolescents with HIV Infection. Pediatrics 118: el745-57.
46. Yu JK, Chen SC, Wang KY et al. 2007. True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bulletin of the World Health Organization 85: 550-4.